Primary Recipient

CALDERA PHARMACEUTICALS, INC.

Amount

$178,915.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Caldera Pharmaceuticals will complete the necessary steps to commercialize its XRflo system. In Phase I we demonstrated the feasibility of this technique to measure unlabeled protein interactions in a fluidic system. XRflo allows for real-time, direct, la